Beximco Pharmaceuticals Limited (DSE: BXPHARMA)

Beximco Pharmaceuticals Revenue

Beximco Pharmaceuticals had revenue of 11.71B BDT in the quarter ending September 30, 2024, with 4.97% growth. This brings the company's revenue in the last twelve months to 44.95B, up 10.60% year-over-year. In the fiscal year ending June 30, 2024, Beximco Pharmaceuticals had annual revenue of 44.39B with 13.05% growth.

• Revenue (ttm): 44.95B
• Revenue Growth: +10.60%
• P/S Ratio: 0.89
• Revenue / Employee: 40.06M
• Employees: 5,700
• Market Cap: 39.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	44.39B	5.12B	13.05%
Jun 30, 2023	39.27B	4.60B	13.26%
Jun 30, 2022	34.67B	5.18B	17.55%
Jun 30, 2021	29.49B	3.88B	15.16%
Jun 30, 2020	25.61B	2.80B	12.25%